Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A randomized placebo-controlled trial of recombinant human interleukin- 11 in cancer patients with severe thrombocytopenia due to chemotherapy

I Tepler, L Elias, JW 2nd Smith, M Hussein, G Rosen, AY Chang, JO Moore, MS Gordon, B Kuca, KJ Beach, JW Loewy, MB Garnick, JA Kaye

Blood (1996) 87 (9): 3607–3614.

https://doi.org/10.1182/blood.V87.9.3607.bloodjournal8793607

Published: 1996

Journal Articles

A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy

MS Gordon, WJ McCaskill-Stevens, LA Battiato, J Loewy, D Loesch, E Breeden, R Hoffman, KJ Beach, B Kuca, J Kaye, GW Jr Sledge

Blood (1996) 87 (9): 3615–3624.

https://doi.org/10.1182/blood.V87.9.3615.bloodjournal8793615

Published: 1996

Journal Articles

A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia

MS Gordon, J Nemunaitis, R Hoffman, RL Paquette, C Rosenfeld, S Manfreda, R Isaacs, SD Nimer

Blood (1995) 85 (11): 3066–3076.

https://doi.org/10.1182/blood.V85.11.3066.bloodjournal85113066

Published: 1995

Journal Articles

In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells

J Tong, MS Gordon, EF Srour, RJ Cooper, A Orazi, I McNiece, R Hoffman

Blood (1993) 82 (3): 784–791.

https://doi.org/10.1182/blood.V82.3.784.784

Published: 1993

Journal Articles

Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia [editorial]

MS Gordon, R Hoffman

Blood (1992) 80 (2): 302–307.

https://doi.org/10.1182/blood.V80.2.302.302

Published: 1992